Search

everythinglearnresearchcommunity

for

Search:↓

MPA increases cancer spread by boosting Eph A2 activity.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Biomedical engineers are crucial for developing better treatments for chronic and autoimmune diseases.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

Alginate is great for tissue engineering because it's safe, easy to use, and helps heal tissues.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Kidney stones form due to factors like urine concentration, calcium deposits, hormones, gut bacteria, and immune response.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Blocking JAK-STAT signaling can lead to hair growth.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Advanced human skin models improve drug development and could replace animal testing.